AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To stay invested in Genesis Minerals, you need to be comfortable with a gold producer whose story revolves around maintaining solid production while managing costs tightly and funding growth projects. The FY2026 result and FY2027 guidance broadly support this narrative, with strong earnings alongside a plan for 270,000 to 300,000 oz at defined AISC ranges. The key near term catalyst remains execution on cost control, while the main risk is still project capital and operating cost pressure, which this update does not fully remove.
The FY2026 earnings announcement is particularly relevant here, with A$1,742.35 million in sales and A$601.76 million in net income highlighting how current operations translate into cash the business can reinvest into Tower Hill and the Leonora and Laverton mill expansions. When you set this against the FY2027 production and AISC guidance, it frames how much headroom Genesis may have to absorb any cost overruns or timing issues on these projects while still funding growth.
Yet against these strong numbers, investors should still be aware that cost overruns on Tower Hill and the mill expansions could...
Read the full narrative on Genesis Minerals (it's free!)
Genesis Minerals' narrative projects A$2.7 billion revenue and A$1.1 billion earnings by 2029. This requires 15.1% yearly revenue growth and about A$498 million earnings increase from A$601.8 million today.
Uncover how Genesis Minerals' forecasts yield a A$8.60 fair value, a 6% upside to its current price.
Some of the most optimistic analysts were already assuming revenue could reach about A$3.3 billion and earnings A$1.7 billion by 2029, which is far more bullish than the consensus view that focuses on risks like potential cost overruns at Tower Hill and the mill expansions; with the new FY2026 result and FY2027 guidance now on the table, you can expect these very different opinions about Genesis’s future to be tested and possibly revised.
Explore 7 other fair value estimates on Genesis Minerals - why the stock might be worth 12% less than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com